Nu Skin Enterprises, Inc.

Nu Skin Enterprises, Inc.

4.10
EUR
+0.01
(+0.20%)
-3.82EPS
223.44MMarket Cap
Nov 04Next Earn

Total Valuation

EUR

As of June 30, 2026, Nu Skin Enterprises, Inc. Class A carries a market capitalization of 223.44M, placing it among publicly traded companies globally. Its enterprise value stands at 286.77M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap223.44M
Enterprise Value286.77M

Important Dates

Nu Skin Enterprises, Inc. Class A's next confirmed earnings release is scheduled for November 4, 2026.

Earnings Date11/4/2026

Share Statistics

As of June 30, 2026, Nu Skin Enterprises, Inc. Class A has 48.70M shares outstanding.

Shares Outstanding48.70M

Valuation Ratios

These figures are as of June 30, 2026. The price-to-sales ratio is 0.19, and the price-to-book ratio stands at 0.47.

PS Ratio0.19
PB Ratio0.47
P/TBV Ratio0.51
P/FCF Ratio24.10
P/OCF Ratio5.02

Enterprise Valuation

As of June 30, 2026, Nu Skin Enterprises, Inc. Class A trades at an EV/EBITDA multiple of 8.27 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.24 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 286.77M versus a market cap of 223.44M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales0.24
EV / EBITDA8.27

Financial Position

As of June 30, 2026, Nu Skin Enterprises, Inc. Class A maintains a current ratio of 1.98, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 48.59, indicating elevated leverage, while an interest coverage ratio of 2.52 demonstrates limited ability to service its debt obligations.

Current Ratio1.98
Quick Ratio0.94
Debt / Equity48.59
Debt / EBITDA6.66
Interest Coverage2.52

Financial Efficiency

EUR

Over the twelve months ended June 30, 2026, Nu Skin Enterprises, Inc. Class A posted a negative return on equity (ROE) of -32.53, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -16.87, reflecting losses generated across the asset base. The company generates approximately 129,785.14 in revenue per employee across its workforce of 9,275.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.28 indicates how many times Nu Skin Enterprises, Inc. Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)-32.53
Return on Assets (ROA)-16.87
Revenue Per Employee129,785.14
Employee Count9,275.00
Inventory Turnover2.28

Taxes

EUR

Over the twelve months ended June 30, 2026, Nu Skin Enterprises, Inc. Class A recorded 166.31M in income tax expense. The company reported a pretax loss of -23.10M and -189.41M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax166.31M

Stock Price Statistics

EUR

As of the close on August 27, 2026, Nu Skin Enterprises, Inc. Class A's stock has declined approximately 60.95% over the past 52 weeks. The 50-day moving average sits at 4.42, while the 200-day moving average is 6.48.

52-Week Price Change-60.95%
50-Day Moving Average4.42
200-Day Moving Average6.48

Income Statement

EUR

Over the twelve months ended June 30, 2026, Nu Skin Enterprises, Inc. Class A generated 1.20B in revenue and converted that into -189.41M in net income, yielding earnings per share of -3.82. EBITDA reached 34.66M, while operating income came in at 61.54M.

Revenue1.20B
Gross Profit832.84M
Operating Income61.54M
Pretax Income-23.10M
Net Income-189.41M
EBITDA34.66M
EBIT-9.11M
Earnings Per Share (EPS)-3.82

Balance Sheet

EUR

As of June 30, 2026, Nu Skin Enterprises, Inc. Class A holds 167.52M in cash and equivalents against 230.85M in total debt, resulting in a net debt position of 21.03M. Total book value stands at 475.06M, with working capital of 220.40M providing operational flexibility.

Cash & Cash Equivalents167.52M
Total Debt230.85M
Net Debt21.03M
Equity (Book Value)475.06M
Book Value Per Share9.75
Working Capital220.40M

Cash Flow

EUR

Nu Skin Enterprises, Inc. Class A produced 44.47M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -35.04M in capital expenditures, free cash flow totaled 9.44M - equivalent to 0.19 per share.

Operating Cash Flow44.47M
Capital Expenditures-35.04M
Free Cash Flow9.44M
FCF Per Share0.19

Margins

Over the twelve months ended June 30, 2026, Nu Skin Enterprises, Inc. Class A posted a gross margin of 69.19, reflecting its pricing power and cost economics. The operating margin of 5.11 and net profit margin of -15.73 provide insight into operational efficiency.

Gross Margin69.19
Operating Margin5.11
Pretax Margin-1.92
Profit Margin-15.73
EBITDA Margin2.88

Dividends & Yields

EUR

Over the twelve months ended June 30, 2026, Nu Skin Enterprises, Inc. Class A paid dividends of 0.21 per share. The dividend payout ratio of -5.39 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 4.15, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 31.01, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Nu Skin Enterprises, Inc. Class A shareholders.

Dividend Per Share0.21
Payout Ratio-5.39
Shareholder Yield31.01
FCF Yield4.15

Scores

As of June 30, 2026, Nu Skin Enterprises, Inc. Class A has an Altman Z-Score of 4.12, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score4.12